RIZZI, Federica Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 4.733
AS - Asia 3.473
EU - Europa 3.353
SA - Sud America 506
AF - Africa 163
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.245
Nazione #
US - Stati Uniti d'America 4.608
SG - Singapore 1.330
CN - Cina 1.224
IT - Italia 777
IE - Irlanda 580
SE - Svezia 430
BR - Brasile 397
FI - Finlandia 361
HK - Hong Kong 280
DE - Germania 272
VN - Vietnam 252
UA - Ucraina 227
NL - Olanda 132
RO - Romania 119
ZA - Sudafrica 113
FR - Francia 111
CA - Canada 96
TR - Turchia 94
GB - Regno Unito 82
AT - Austria 73
RU - Federazione Russa 63
IN - India 60
AR - Argentina 42
BD - Bangladesh 42
IR - Iran 40
ID - Indonesia 33
BE - Belgio 30
JP - Giappone 22
KR - Corea 22
CZ - Repubblica Ceca 19
CI - Costa d'Avorio 18
EC - Ecuador 16
CO - Colombia 15
MX - Messico 15
ES - Italia 14
PL - Polonia 13
IQ - Iraq 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
AU - Australia 9
PK - Pakistan 9
CH - Svizzera 8
LT - Lituania 8
AZ - Azerbaigian 7
CL - Cile 7
PY - Paraguay 7
UZ - Uzbekistan 7
EG - Egitto 6
IL - Israele 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
EU - Europa 5
KE - Kenya 5
TN - Tunisia 5
BG - Bulgaria 4
MA - Marocco 4
NP - Nepal 4
PA - Panama 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BI - Burundi 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
OM - Oman 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BW - Botswana 1
DM - Dominica 1
GA - Gabon 1
HN - Honduras 1
LV - Lettonia 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
SR - Suriname 1
Totale 12.245
Città #
Singapore 653
Ashburn 627
Dublin 576
Chandler 520
Santa Clara 356
Dallas 315
Hong Kong 278
Jacksonville 272
Beijing 255
Parma 236
Ann Arbor 230
Dearborn 211
Nanjing 145
Boardman 141
Focsani 112
Johannesburg 110
Shanghai 106
Princeton 93
Ho Chi Minh City 92
San Mateo 91
Los Angeles 84
Izmir 72
Munich 62
Jinan 60
Vienna 57
Toronto 55
New York 52
Shenyang 49
Hefei 47
Wilmington 47
Marseille 46
Hanoi 45
Helsinki 43
São Paulo 43
Hebei 39
Buffalo 38
Moscow 38
Nanchang 38
Turku 36
Des Moines 34
Council Bluffs 33
Guangzhou 33
Changsha 32
Columbus 31
Milan 29
Bologna 28
Brussels 28
Nuremberg 28
Kunming 27
Leawood 27
Chicago 25
Fremont 25
Zhengzhou 25
London 24
Jakarta 23
Haikou 22
Tokyo 22
Rome 21
Tianjin 21
Houston 20
The Dalles 20
Abidjan 18
Falls Church 18
Jiaxing 18
Redmond 18
Seattle 18
Augusta 16
Brooklyn 16
Dong Ket 16
Seoul 16
Modena 15
Belo Horizonte 14
Frankfurt am Main 14
Montreal 14
Stockholm 14
Piacenza 13
Taiyuan 13
Taizhou 13
Trieste 13
Ardabil 12
Ardea 12
Atlanta 12
Denver 12
Phoenix 12
Warsaw 12
Biên Hòa 11
Bremen 11
Da Nang 10
Haiphong 10
Las Vegas 10
Manchester 10
Ningbo 10
Norwalk 10
Reggio Emilia 10
Amsterdam 9
Brno 9
Chengdu 9
Chennai 9
Hangzhou 9
Monmouth Junction 9
Totale 7.443
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 438
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 278
Ionizing Radiation Effects on Hs 578Bst Microtubules 277
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 241
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 216
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 208
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 195
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 192
Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies 184
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 173
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 172
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 171
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 168
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 164
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 161
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 159
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 158
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 155
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 151
SERS-based methods for the detection of genomic biomarkers of cancer 147
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 145
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 144
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 144
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 144
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 144
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 139
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 137
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 136
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 135
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 134
Effects of Clusterin knock down on prostate cancer progression in the tramp model 132
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 131
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 131
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 130
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 130
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 130
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 129
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 129
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 127
Clusterin is epigenetically repressed in human prostate cancer cells 126
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 124
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 123
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 123
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 123
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 123
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 120
Clusterin (CLU): From one gene and two transcripts to many proteins 116
Clusterin (CLU) and prostate cancer 116
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 115
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 115
Chemoprevention of human prostate cancer by oral administration of green tea catechins 115
Anticancer activity of green tea polyphenols in prostate gland 114
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 114
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 112
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 112
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 112
Clusterin (CLU) and lung cancer 110
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 110
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 110
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 109
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 104
Clusterin is epigenetically repressed in human prostate cancer. 101
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 96
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 96
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 95
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 94
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 93
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 92
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 92
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 91
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 90
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 90
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 90
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 89
Il tè verde nella chemoprevenzione oncologica 89
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 89
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 87
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 87
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 87
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 87
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 86
Redox Status and Proteostasis in Ageing and Disease 86
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 85
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 84
Green tea polyphenols and prostate cancer chemoprevention 81
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 79
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 79
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 79
Espressione in forma ricombinante di differenti forme di clusterina 78
Nuclear CLU (nCLU) and the fate of the cell 78
Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives? 73
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 73
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 73
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 70
Targeting clusterin in prostate cancer 70
Prognostic role of clusterin in resected adenocarcinomas of the lung 63
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 63
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 62
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 60
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 60
Totale 12.342
Categoria #
all - tutte 40.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021608 0 0 0 0 0 53 78 49 159 47 184 38
2021/2022571 22 46 8 16 29 16 71 75 26 44 67 151
2022/20232.055 186 208 155 173 137 232 22 137 669 14 82 40
2023/2024746 63 53 30 24 88 148 49 43 23 54 53 118
2024/20252.768 62 148 133 189 289 312 109 103 342 204 442 435
2025/20263.019 570 403 669 467 790 120 0 0 0 0 0 0
Totale 12.410